← Back to Search

Ventilation

Comparison of Oxygenation Between Nasal PAP vs Nasal During Propofol-based Sedation for EUS (SuperNo2VA Trial)

N/A
Waitlist Available
Led By john M DeWitt, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 120 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial tests different ways to help patients with high BMI or sleep apnea breathe better during and after a medical procedure. It uses extra oxygen and a bag-mask to push air into the lungs. These methods aim to ensure patients get enough oxygen and maintain open airways.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 120 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Oxygen
Secondary study objectives
Modified Observer's Assessment and Alertness/Sedation Scale (MOAAS)
Procedural Interruptions
Total Amount of Propofol for Adequate Sedation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SuperNO2VAExperimental Treatment1 Intervention
SuperNO2VA is CPAP device to deliver oxygen with nasal mask rather than with facial mask
Group II: Facial maskActive Control1 Intervention
facial mask for oxygen delivery

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
1,040 Previous Clinical Trials
1,220,053 Total Patients Enrolled
Vyaire MedicalIndustry Sponsor
9 Previous Clinical Trials
1,013 Total Patients Enrolled
john M DeWitt, MDPrincipal InvestigatorIndiana University
John M DeWitt, MDPrincipal InvestigatorIndiana University
1 Previous Clinical Trials
12 Total Patients Enrolled
~2 spots leftby Dec 2025